Acer Therapeutics (ACER) PT Lowered to $10 at H.C. Wainwright as EDSIVO Receives a CRL
Tweet Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju reiterated his Buy rating but cut the price target on Acer Therapeutics (NASDAQ: ACER) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
